ventricular tachycardia

Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.

Ventricular Tachycardia



Ventricular tachycardia (V-tach) is a rapid heart beat that originates in one of the lower chambers (the ventricles) of the heart. To be classified as tachycardia, the heart rate is usually at least 100 beats per minute.


A rapid heart rate can originate in either the left or right ventricle. Ventricular tachycardia which lasts more than 30 seconds is referred to as sustained ventricular tachycardia. A period of three to five rapid beats is called a salvo, and six beats or more lasting less than 30 seconds is called nonsustained ventricular tachycardia. Rapid ventricular rhythms are more serious than rapid atrial rhythms because they make the heart extremely inefficient. They also tend to cause more severe symptoms, and have a much greater tendency to result in death.
Although generally considered to be among the life-threatening abnormal rhythms, harmless forms of sustained V-tach do exist. These occur in people without any structural heart disease.

Causes and symptoms

Most ventricular tachycardias are associated with serious heart disease such as coronary artery blockage, cardiomyopathy, or valvular heart disease. V-tach is often triggered by an extra beat originating in either the right or left ventricle. It also occurs frequently in connection with a heart attack. V-tach commonly occurs within 24 hours of the start of the attack. It must be treated quickly to prevent fibrillation. After 48 to 72 hours of the heart attack, the risk of ventricular tachycardia is small. However, people who have suffered severe damage to the larger anterior wall of the heart have a second danger period, because V-tach often occurs during convalescence from this type of heart attack.
Sustained ventricular tachycardia prevents the ventricles from filling adequately so the heart can not pump normally. This results in loss of blood pressure, and can lead to a loss of consciousness and to heart failure.
The individual with V-tach almost always experiences palpitation, though some episodes cause no symptoms at all.


Diagnosis is easily made with an electrocardiogram.


Any episode of ventricular tachycardia that causes symptoms needs to be treated. An episode that lasts more than 30 seconds, even without symptoms, also needs to be treated. Drug therapy can be given intravenously to suppress episodes of V-tach. If blood pressure falls below normal, a person will need electric cardioversion ("shock") immediately.


With appropriate drug or surgical treatment, ventricular tachycardia can be controlled in most people.


A person susceptible to sustained ventricular tachycardia often has a small abnormal area in the ventricles that is the source of the trigger event. This area can sometimes be surgically removed. If surgery is not an option, and drug therapy is not effective, a device called an automatic cardioverter-defibrillator may be implanted.

Key terms

Atrial — Having to do with the upper chambers of the heart.
Cardiomyopathy — A disease of the heart muscle.
Cardioversion — A electrical shock delivered to the heart to restore a normal rhythm.
Coronary artery — The artery that supplies blood to the heart muscle itself.
Electrocardiogram — A visual representation of the heart beat.
Fibrillation — Rapid, uncoordinated, quivering of the heart.
Palpitations — Uncomfortable feeling of the heart beat in the chest.
Valvular — Having to do with the valves inside the heart.



American Heart Association. 7320 Greenville Ave. Dallas, TX 75231. (214) 373-6300.
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.


abnormally rapid heart rate, usually taken to be over 100 beats per minute. adj., adj tachycar´diac.
A, Sinus tachycardia; B, Ventricular tachycardia. From Chernecky, 2001.
antidromic circus movement tachycardia a supraventricular tachycardia supported by a reentry circuit that uses the atrioventricular node in the retrograde direction and an accessory pathway in the anterograde direction; this produces a broad QRS rhythm indistinguishable from ventricular tachycardia. Such a tachycardia may also use two accessory pathways (one anterograde and one retrograde) and not involve the AV node at all.
atrial tachycardia a rapid heart rate, between 140 and 250 beats per minute, with the ectopic focus in the atria and with no participation by the atrioventricular node or the sinoatrial node. It is recognizable on the electrocardiogram because the P wave precedes the QRS complex, as opposed to being merged with it or following it. This condition is usually associated with atrioventricular block or digitalis toxicity.
benign ventricular tachycardia tachycardia originating in the ventricles, not associated with structural heart disease or significant hemodynamic symptoms.
bidirectional ventricular tachycardia (bifascicular ventricular tachycardia) a ventricular arrhythmia characterized by heart rates of 90 to 160 beats per minute, alternating right and left axis deviation, ectopic focus that alternates between the anterior superior and posterior inferior fascicles, and a right bundle branch block pattern in lead V1; seen in digitalis toxicity and other conditions.
chaotic atrial tachycardia an ectopic atrial tachycardia due to multifocal activity, characterized by at least three different shapes of P waves on the electrocardiogram; often associated with chronic obstructive lung disease.
circus movement tachycardia (CMT) a reentry circuit that uses an accessory pathway or pathways; there are two subtypes, antidromic and orthodromic circus movement tachycardia.
ectopic tachycardia rapid heart action in response to impulses arising outside the sinoatrial node.
junctional tachycardia rhythm at the rate of 100 to 140 beats per minute that arises in response to impulses originating in the atrioventricular junction, i.e., the atrioventricular node. It is often seen with digitalis toxicity and is due to triggered activity, but it may also be due to altered automaticity. In the case of digitalis toxicity, the term may be used to encompass the entire span of junctional rates with this condition, i.e., approximately 70 to 140 beats per minute.
monomorphic ventricular tachycardia a type that has a uniform beat-to-beat QRS morphology.
nonsustained ventricular tachycardia a type that terminates spontaneously within 30 seconds and does not lead to hemodynamic collapse.
orthodromic circus movement tachycardia a supraventricular tachycardia supported by a reentry circuit that uses the atrioventricular node in the anterograde direction and an accessory pathway in the retrograde direction, producing a narrow QRS complex.
orthostatic tachycardia disproportionate rapidity of the heart rate on arising from a reclining to a standing position.
paroxysmal tachycardia rapid heart action that starts and stops abruptly.
paroxysmal atrial tachycardia paroxysmal supraventricular tachycardia.
paroxysmal supraventricular tachycardia (PSVT) a narrow QRS tachycardia that begins and ends abruptly; it may be terminated with a vagal maneuver. It has two common mechanisms, atrioventricular nodal reentry and circus movement that uses the atrioventricular node anterogradely and an accessory pathway retrogradely. On the electrocardiogram it is characterized by abrupt onset, and mechanisms are differentiated by the relation of the P wave to the QRS complex.
polymorphic ventricular tachycardia a type that has a constantly, and sometimes subtly, changing beat-to-beat QRS configuration.
potentially malignant ventricular tachycardia a type that is not associated with structural heart disease or hemodynamically important cardiac symptoms but is sometimes associated with left ventricular dysfunction.
sinus tachycardia (ST) a rapid rhythm originating in the sinoatrial node with a rate of usually 100 to 160 beats per minute; conduction through the ventricles is normal. During exercise or stress this is normal, but if it occurs during rest it is abnormal.
supraventricular tachycardia a combination of junctional tachycardia and atrial tachycardia.
sustained ventricular tachycardia tachycardia that lasts more than 30 seconds and leads to hemodynamic collapse.
ventricular tachycardia an abnormally rapid ventricular rhythm with aberrant ventricular excitation, characterized by at least three consecutive ventricular complexes of more than 100 beats per minute. It is generated within the ventricle and is most often associated with atrioventricular dissociation.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

ven·tric·u·lar tach·y·car·di·a

paroxysmal tachycardia originating in an ectopic focus in the ventricle.
See also: torsade de pointes.
Farlex Partner Medical Dictionary © Farlex 2012

ventricular tachycardia

V tach, wide-complex tachycardia Cardiology A common, potentially life threatening abnormal rapid–160–240 beats/minheart beat initiated in the ventricles, characterized by 3 or more consecutive premature ventricular beats; VT may compromise systemic pumping of blood Triggers Spontaneous, post-acute MI, cardiomyopathy, mitral valve prolapse, myocarditis, post-heart surgery, antiarrhythmics, ↓ potassium, pH–acid-base changes, ↓ O2 Types Nonsustained–eg, lasting < 30 secs, sustained, > 30 secs. See Torsade de pointes.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

ven·tric·u·lar tach·y·car·di·a

(ven-trik'yū-lăr tak'i-kahr'dē-ă)
A heart rate exceeding 100 beats per minute driven by an ectopic ventricular focus.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

ventricular tachycardia

A dangerous disorder of heart rhythm in which the contraction of the lower main pumping chambers is initiated from uncontrolled electrical impulses arising in the ventricles instead of in the SINOATRIAL NODE. The heart rate is abnormally fast-between 140 and 220 beats per minute and this may persist for hours or days and progress to severe HEART FAILURE and death. Treatment is by the use of drugs such as lignocaine (lidocaine) to regulate the rate or by electrical DEFIBRILLATION.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
References in periodicals archive ?
A mutation in the RyR2 gene is present in approximately 60% of patients with catecholaminergic polymorphic ventricular tachycardia (1).
The five patients in the study had undergone catheter ablation procedures and their ventricular tachycardia returned, or they were unable to go through the procedure because of other high-risk medical conditions.
Caption: Figure 3: (a) Intracardiac electrogram showing bipolar prepotential preceding the surface QRS by 35 milliseconds (arrow) and unipolar QS pattern (asterisk) recorded at the ablation site during ventricular tachycardia. (b) Programmed stimulation during cryoenergy application did not induce ventricular arrhythmia.
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acutemyocardial iNfarcTion trial [VALIANT] Registry).
In the absence of contraindications (such as QT lengthening or polymorphic ventricular tachycardia), amiodarone is generally the antiarrhythmic drug of choice and has been validated in many clinical trials.
Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation.
Useful clinical criteria for the diagnosis of ventricular tachycardia. Am J Med 1988;84(1):53-56.
Typically, as a result of this impact, the morphology appears initially uneven and undulating, described as either a polymorphic ventricular tachycardia (PVT) or Torsade de Pointes.
In the present study, the frequency of Ventricular tachycardia (VT) was seen more in anterolateral MI than in anteroseptal MI which goes well with the study done by Horvat D et al.
The transaction is intended to expand Audentes' range with the addition of Cardiogen's lead programme for the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia. No therapies have yet been approved for treating CASQ2-CPVT, an inherited disease caused by mutations in the CASQ2 gene.
Audentes said it plans to rapidly advance Cardiogen's lead program for the CASQ2subtype of catecholaminergic polymorphic ventricular tachycardia (CASQ2-CPVT) into clinical development.
Determining the need to make the drug available to treat pediatric patients in Japan, the Japanese Ministry of Health, Labour and Welfare's Council for Pediatric Pharmacotherapy approved Tambocor as indicated for the treatment of tachyarrythmia (paroxysmal atrial fibrillation/flutter, paroxysmal superventricular tachycardia, ventricular tachycardia) in pediatric patients in May 2010.

Full browser ?